Asian Journal of Innovation and Policy

Asian Society for Innovation and Policy (아시아기술혁신학회)
권호 표지
DOI QR코드

DOI QR Code

Digital Transformation Shift in Global Pharmaceutical Industry Going through the Covid-19 Pandemic Era

  • Il Seo (College of Pharmacy, Chungbuk National University) ;
  • Hak Kyun Yang (College of Pharmacy, Chungbuk National University) ;
  • Min Joon Seo (College of Pharmacy, Chungbuk National University) ;
  • Sung Hyun Kim (College of Pharmacy, Chungbuk National University) ;
  • Jin Tae Hong (College of Pharmacy and Medical Research Center, Chungbuk National University)
  • Received : 2022.08.20
  • Accepted : 2023.05.06
  • Published : 2023.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

With the advent of the '4th Industrial Revolution', digitalization using AI (Artificial Intelligence), big data, IoT (Internet of Things), cloud computing and mobile is accelerating across all industries and global companies have fundamentally reorganized customer experiences, business models, and operations centering on digital transformation. Business innovation drives productivity improvement, process simplification, price, competitiveness and sustainable expansion. Whether digital transformation will be necessary for the current industrial environment is no longer important, and how quickly companies achieve digitalization has emerged as the utmost crucial element in industrial continuity. As non-face-to-face and remote technologies have begun in earnest, and accelerated in the pharmaceutical industry. They are looking for ways to provide value, generate profits, improve efficiency, and sustain the future. Compared to other industries, the pharmaceutical-related sectors have shown high interest in digital transformation especially to reduce costs and meet the challenge of delivering products during the pandemic environment.

Keywords

Acknowledgement

I appreciate all the anonymous reviewers who could improve this article. In addition, I was thankful for my colleagues at SamsungBiologics and Chungbuk National University who made invaluable contributions with deep insights.

References

  1. Aditya Kudumala, Todd Konersmann and et al, (2021): Biopharma digital transformation: Gain an edge with leapfrog digital innovation. Digital transformation in pharma is at an inflection point : Deloitte Insight Report : Deloitte Center for Health Solution.
  2. Bae, Su-in et al, (2017): 4th Industrial Innovation and Bio Pharmaceuticals Industry: KPBMA Brief, 2017. 9. Vol. 13: Korea Bio-Economy Research Center.
  3. Deloitte Insight, Article: Biopharma digital transformation: Gain an edge with leapfrog digital innovation, Aditya Kudumala et al, December 8, 2021.
  4. Glenn Hole, Anastasia S. Hoe, Ian McFalone-Shaw, (2021): Digitalization in pharmaceutical industry: What to focus on under the digital implementation process:https://www.sciencedirect.com/science/article/pii/S2590156721000244.
  5. Globaldata, (2021): AI and big data will continue to disrupt pharmaceutical sector, according to healthcare industry professionals surveyed by GlobalData: https://www.globaldata.com/media/pharma/ai-big-data-will-continue-disrupt-pharmaceutical-sector-according-healthcare-industry-professionals-surveyed-globaldata.
  6. Globaldata, Healthcare (2023): AI continues to gain momentum in the biopharmaceutical industry in 2023, according to survey data published in GlobalData's The state of the Biopharmaceutical Industry-2023 report by GlobalData:https://www.pharmaceutical-technology.com/comment/ai-momentum-biopharmaceutical.
  7. Nisarg A. Patel and Atul J. Butte, (2020): Characteristics and challenges of the clinical pipeline of digital therapeutics: npj digital medicine, 159(2020). Vol.3.
  8. James Choi, (2021): Setting the Right Goal: Go Digital, Not Paperless: Samsung Biologics Co., Ltd.
  9. Jeong, Jae-hoo, (2021): Digital Paradigm of Industry through Digital Therapeutics: Pharmaceutical bio-industry in a Paradigm Shift: KMPA Brief, 2021. 7. Vol. 22.
  10. Kevin Weier and Yashita Vedi, (2021): Biopharma digital transformation: Gain an edge with leapfrog digital innovation : Deloitte Insight Report : Deloitte Center for Health Solution.
  11. Kim, Hwe-jong, (2021): AI-based new drug development paradigm Shift.: Pharmaceutical bio-industry in a Paradigm Shift: KMPA Brief, 2021. 7. Vol. 22.
  12. Kim, Ki-bong, Han, Gun-Hee, (2020): A Study of the Digital Healthcare Industry in the Fourth Industrial Revolution: Jurnal of Convergence for Information Technology Vol. 10. No. 3, pp. 7-15, 2020, e-ISSN 2586-4440.
  13. Yookyeong Kim, Jeong-Hyun Yoon (2020): The Fourth Industrial Revolution and Changes of Pharmacists' Roles in the Future: 2020;30(4):217-225, Korean Journal of Clinical Pharmacy, December 31, 2020.
  14. Kim Tae-hyeong (2020): Bio Big Data-Data Saves Lives, Bio Economy Report, ISSN2508-6820 : Korea Bio-Economy Research Center.
  15. Marcus Ehrdardt, Peter Behner, (2021): Digitalization in pharma: Gaining an edge in operations: Strategy &, PwC.
  16. Moon, Cho-hye, Park, Soo-kyeong, (2021): Digitalization Trend in the Cold Chain of Bio-Parmaceuticals: Issue Brief: Industricl Technology Research Center of KDB Future Strategy Institute.
  17. Park, An-seon, Lee, Seung-min, (2020): Status analysis and development direction of digutal Therapeutics : Insight Report : ETRI (Electronics and Telecommunications Research Institute).
  18. Park, An-seon, Lee, Seung-min, (2020): Status analysis and development direction of digutal Therapeutics : Insight Report : ETRI (Electronics and Telecommunications Research Institute).
  19. Saly Romero-Torres (Thermo Fisher Scientific), (2021): The role of digital transformation in achieving Pharma 4.0.
  20. Europen Pharmaceutical Review:The role of digital transformation in achieving Pharma 4.0.
  21. The Enterprisers Project: an online publication and community, https://enterprisersproject. com/what-is-digital-transformation.
  22. Tim Sandle, (2022): Maturing Pharma 4.0: How Digital Transformation Continues To Reshape Pharmaceuticals : BiopharmaTrend.com
  23. Shehmir Javaid, (2021): Digital Transformation , Healthcare: Digital Transformation in Pharma: Technologies & Trends : https://research.aimultiple.com/digital-transformation-pharma
  24. Federal Register. Medical devices; medical software devices; Notice of public workshop. Published July 15, 1996 Vol. 61, No. 136. (Accessed July 11, 2022).
  25. Food and Drug Administration. Policy for device software functions and mobile medical applications; guidance for industry and food and drug administration staff. Available at: https://www.fda.gov/media/80958/download(accessed July 11, 2022).
  26. Food and Drug Administration. 21st century cures act. Available at: https://www. fda.gov/regulatory-information/selected-amendments-fdc-act/21st-century-curesact(Accessed October 31, 2022).